Sg3 Management, LLC Ascendis Pharma A/S Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$99.42 - $131.97 $198,840 - $263,940	2,000 New	2,000 $244,000
Q4 2021 Feb 15, 2022	SELL	$127.1 - $169.66 $63,550 - $84,830	-500 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$112.67 - $176.92 $394,345 - $619,220	-3,500 Reduced 87.5%	500 $80,000
Q2 2021 Aug 16, 2021	BUY	$121.62 - $145.29 $486,480 - $581,160	4,000 New	4,000 $526,000

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.